title: Are more complex implantable cardioverter defibrillators associated with an increased mortality? Lessons learned from clinical trials.
abstract: We compared 1-year survival in patients receiving implantable cardioverter defibrillators (ICDs) that provide only shock therapy with more advanced ICDs that provide antitachycardia pacing, bradycardia pacing, low-energy cardioversion, and advanced detection algorithms. Outcome in patients with advanced-generation ICD systems was similar or improved compared with outcome in patients receiving ICDs with only monophasic shock.
authors.affiliation: Department of Medicine, Medical College of Virginia and the McGuire VA Medical Center, Richmond 23298-0053, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Ellenbogen
authors.forename: A E
authors.initials: AE
authors.lastname: Epstein
authors.forename: M A
authors.initials: MA
authors.lastname: Wood
authors.forename: B S
authors.initials: BS
authors.lastname: Stambler
authors.forename: G N
authors.initials: GN
authors.lastname: Kay
authors.forename: V J
authors.initials: VJ
authors.lastname: Plumb
authors.forename: L
authors.initials: L
authors.lastname: Voshage-Stahl
authors.forename: M L
authors.initials: ML
authors.lastname: Hull
mesh_terms: D002986:Clinical Trials as Topic; D016757:Death, Sudden, Cardiac / Q000209:etiology*; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D004867:Equipment Design; D004868:Equipment Failure; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis; D013610:Tachycardia / Q000150:complications / Q000401:mortality* / Q000628:therapy